3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
6
Endocrine
6
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
14
Colorectal Neoplasms
13
Stomach Neoplasms
12
Pancreatic Neoplasms
11
Liver Neoplasms
8
Neuroendocrine Tumors
7
Neoplasm Metastasis
6
Gastrointestinal Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Neoplasms
3
Digestive System Neoplasms
3
Gastrointestinal Stromal Tumors
2
Gastro-enteropancreatic neuroendocrine tumor
2
Gallbladder Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma Of Esophagus
2
Adenocarcinoma
2
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Thrombocytosis
1
Stomach Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Salivary Gland Neoplasms
1
Interventions
Sunitinib
5
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
sapanisertib
1
napabucasin
1
lutetium Lu 177 dotatate
1
lanreotide
1
irinotecan sucrosofate
1
cabozantinib
1
aflibercept
1
abemaciclib
1
X-Rays
1
Wound Healing
1
Taxes
1
Plastic Surgery Procedures
1
Phantoms, Imaging
1
Paclitaxel
1
Oxaliplatin
1
Octreotide
1
Methods
1
Melphalan
1
Leucovorin
1
Irinotecan
1
Histocompatibility Testing
1
Gemcitabine
1
Fluorouracil
1
Everolimus
1
Cytoreduction Surgical Procedures
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenoma, Islet Cell
×
Everolimus
×
Gastrointestinal
×
Clear all
NCT05477576
2026-03-30
ACTION-1
RayzeBio, Inc.
Phase 3
Recruiting
338 enrolled